| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,035 |
3,240 |
$181K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,784 |
1,420 |
$73K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,688 |
1,387 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,989 |
1,497 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,604 |
1,033 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,002 |
518 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,293 |
671 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
48 |
43 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
156 |
150 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
54 |
38 |
$665.38 |
| 81002 |
|
264 |
216 |
$526.05 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
314 |
216 |
$347.97 |
| 87807 |
|
26 |
26 |
$253.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
417 |
297 |
$181.05 |
| 86328 |
|
265 |
140 |
$63.32 |